These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34378512)

  • 21. Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment.
    Green BW; Labagnara K; Feiertag N; Gupta K; Donnelly J; Watts KL; Crivelli JJ; Assimos DG; Small AC
    Urology; 2022 Dec; 170():46-52. PubMed ID: 36183747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada.
    de Oliveira C; Bremner KE; Ni A; Alibhai SM; Laporte A; Krahn MD
    J Cancer Surviv; 2014 Mar; 8(1):9-20. PubMed ID: 23975612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and financial toxicity in patients with renal cell carcinoma.
    Staehler MD; Battle DJ; Bergerot CD; Pal SK; Penson DF
    World J Urol; 2021 Jul; 39(7):2559-2565. PubMed ID: 33090258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
    Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
    Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
    Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
    Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
    O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
    J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
    BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
    McLean L; Hong W; McLachlan SA
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
    Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
    Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Cancer Treatment-Related Financial Distress Worsen Over Time?
    Hussaini SMQ; Chino F; Rushing C; Samsa G; Altomare I; Nicolla J; Peppercorn J; Zafar SY
    N C Med J; 2021; 82(1):14-20. PubMed ID: 33397749
    [No Abstract]   [Full Text] [Related]  

  • 33. Financial Toxicity in Patients With Resected Lung Cancer.
    Deboever N; Eisenberg M; Hofstetter WL; Mehran RJ; Rice DC; Roth J; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Antonoff MB; Rajaram R
    Ann Surg; 2023 Dec; 278(6):1038-1044. PubMed ID: 37249193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry.
    Mollica MA; Zaleta AK; Gallicchio L; Brick R; Jacobsen PB; Tonorezos E; Castro KM; Miller MF
    Support Care Cancer; 2024 Jan; 32(2):137. PubMed ID: 38286846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
    Bhoo-Pathy N; Ng CW; Lim GC; Tamin NSI; Sullivan R; Bhoo-Pathy NT; Abdullah MM; Kimman M; Subramaniam S; Saad M; Taib NA; Chang KM; Goh PP; Yip CH
    J Oncol Pract; 2019 Jun; 15(6):e537-e546. PubMed ID: 31112479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis.
    Azzani M; Atroosh WM; Anbazhagan D; Kumarasamy V; Abdalla MMI
    Front Public Health; 2023; 11():1266533. PubMed ID: 38229668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobile Application to Identify Cancer Treatment-Related Financial Assistance: Results of a Randomized Controlled Trial.
    Tarnasky AM; Tran GN; Nicolla J; Friedman FAP; Wolf S; Troy JD; Sung AD; Shah K; Oury J; Thompson JC; Gagosian B; Pollak KI; Manners I; Zafar SY
    JCO Oncol Pract; 2021 Oct; 17(10):e1440-e1449. PubMed ID: 33797952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008-2012.
    Guy GP; Yabroff KR; Ekwueme DU; Virgo KS; Han X; Banegas MP; Soni A; Zheng Z; Chawla N; Geiger AM
    Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S489-97. PubMed ID: 26590644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.